文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

HPV疫苗接种后不明原因不良健康事件与传染性单核细胞增多症的关联:丹麦全国匹配病例对照研究

Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study.
PubMed 文献 · Vaccine · 2020-07-02

丹麦全国匹配病例对照研究纳入1217例接种HPV疫苗后疑似不良事件女性及6085例对照,评估接种前后EBV感染检测与疑似不良事件的关联。结果显示病例组在接种前后EBV检测率更高,EBV阳性(OR 4.52)与阴性(OR 20.99)均与疑似不良事件 odds 升高相关,仅5例为急性/近期EBV感染。结论认为EBV感染迟发症状的误判并非丹麦女性接种HPV疫苗后疑似不良事件的主要解释,结果更可能由原发病偏倚所致。

要点

  • 病例组接种前后EBV检测率高于对照(3.1% vs 0.5%),提示检测行为差异。
  • EBV阳性与阴性均与疑似不良事件 odds 升高相关,仅5例为急性/近期感染。
  • EBV感染误判不能解释大多数HPV疫苗疑似不良事件,需警惕原发病偏倚。

核心结论

  • EBV感染迟发症状的误判并非丹麦女性接种HPV疫苗后疑似不良事件的主要解释。
  • EBV不能排除为极少数疑似不良事件的解释因素,但结果更可能由原发病偏倚解释。

研究设计与样本

  • 丹麦全国注册匹配病例对照研究,病例为2011至2017年接种HPV疫苗后疑似不良事件的女性。
  • 每例匹配5名接种HPV疫苗且无疑似不良事件的女性作为对照,共1217例病例和6085名对照。
  • EBV感染信息来自丹麦微生物数据库,评估三个时段:首剂HPV疫苗前、接种前后、2010-2017年研究期间任意时间。
  • 采用多重logistic回归估计EBV与疑似不良事件的关联。

主要发现

  • 病例组38例(3.1%)在接种前后接受EBV检测,对照组31例(0.5%)。
  • 接种前后EBV检测阳性与疑似不良事件相关(OR 4.52,95%CI 2.68-7.63)。
  • 接种前后EBV检测阴性也与疑似不良事件相关(OR 20.99,95%CI 5.81-75.79)。
  • 该时段仅5名女性被分类为急性/近期EBV感染。

临床怎么用

  • 评估HPV疫苗接种后疑似不良事件时,应关注EBV检测行为差异可能导致的偏倚。
  • 对疑似不良事件女性,不应仅凭EBV检测阳性或阴性结果推断疫苗因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Denmark, the acceptance of the HPV vaccination program has been threatened by reports of suspected adverse events. Epstein Barr Virus (EBV) infection is associated with symptoms of long-lasting tiredness and may be misinterpreted as HPV vaccine adverse events. The main aim of this study was to examine if EBV infection around time of HPV vaccination was a risk factor for later suspected vaccine adverse events. METHODS: The study was a nationwide register-based matched case-control study. Cases were females vaccinated against HPV in the period 2011 throughout 2017 with suspected adverse events. For each case, five HPV vaccinated females without suspected adverse events were selected. Information about EBV infection was obtained from the Danish Microbiology Database and assessed for three time periods: (1) before first HPV vaccination, (2) around time of HPV vaccination, and (3) any time during the study period 2010-2017. Multiple logistic regression was used to estimate the association between EBV and suspected adverse events. RESULTS: We identified 1217 cases, matched to 6085 controls. A higher proportion of cases (38; 3.1%) than controls (31; 0.5%) were tested for EBV around time of HPV vaccination and cases had elevated odds for testing both EBV positive (OR 4.52, 95% CI 2.68-7.63) and EBV negative (OR 20.99, 95% CI 5.81-75.79). Only five females were classified with acute/recent EVB infection in this period. CONCLUSION: Misinterpretation of EBV infection late symptoms is not a leading explanation for Danish females experiencing suspected adverse events after HPV vaccination. Although EBV cannot be excluded as an explanatory factor for a very small proportion of suspected adverse events, the findings are more likely explained by protopathic bias, i.e. the fact that a larger proportion of females suspecting adverse events are tested for EBV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Krogsgaard LW, Helmuth IG, Bech BH, et al. Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study. Vaccine. 2020. PMID: 32624249. doi:10.1016/j.vaccine.2020.06.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。